Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia: a review

doi:10.3877/cma.j.issn.2095-5782.2022.01.012

Abstract

Abstract:

Benign prostatic hyperplasia is a common condition in older men and the lower urinary tract symptoms caused by it negatively affect the quality of life. In severe cases, drug treatment and even surgical intervention are required. In recent years, prostatic arterial embolization has made significant progress in the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia, and it is expected to be more widely used in clinical practice. In this article, we will review the development process, applicable population, efficacy assessments, predictive factors, adverse reactions and complications of prostatic arterial embolization, so as to improve the understanding of the treatment.

Key words: Prostatic arterial embolization, Benign prostatic hyperplasia, Lower urinary tract symptoms

Jiali Lin, Zhuting Fang. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia: a review[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(01): 65-69.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2022.01.012

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2022/V10/I01/65

References 25

[1]	McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia[J].J Urol, 2011, 185(5): 1793-1803.
[2]	Sohn JH, Choi YS, Kim SJ, et al. Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants[J]. Korean J Urol, 2011, 52(3): 178-183.
[3]	DeMeritt JS, Elmasri FF, Esposito MP, et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization[J]. J Vasc Interv Radiol, 2000, 11(6): 767-770.
[4]	Carnevale FC, Antunes AA, da Motta Leal Filho JM, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients[J]. Cardiovasc Intervent Radiol, 2010, 33(2): 355-361.
[5]	方主亭, 颜志平, 唐仪, 等. 前列腺动脉栓塞治疗犬前列腺增生的初步研究[J]. 中华放射学杂志, 2013(6): 551-554.
[6]	de Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification[J]. Cardiovasc Intervent Radiol, 2015, 38(4): 855-861.
[7]	Torres D, Costa NV, Pisco J, et al. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm embospheres[J]. J Vasc Interv Radiol, 2019, 30(5): 638-644.
[8]	Wang MQ, Zhang JL, Xin HN, et al. Comparison of clinical outcomes of prostatic artery embolization with 50-μm plus 100-μm polyvinyl alcohol (PVA) particles versus 100-μm PVA particles alone: a prospective randomized trial[J]. J Vasc Interv Radiol, 2018, 29(12): 1694-1702.
[9]	Carnevale FC, Moreira AM, de Assis AM, et al. Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years' experience[J]. Radiology, 2020, 296(2): 444-451.
[10]	Bilhim T, Pisco J, Pereira JA, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia[J]. Radiology, 2016, 281(1): 289-300.
[11]	Pisco JM, Bilhim T, Costa NV, et al. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia[J]. Eur Urol, 2020, 77(3): 354-362.
[12]	Tang Y, Zhang JH, Zhu YB, et al. Effect of superselective prostatic artery embolization on benign prostatic hyperplasia[J]. Abdom Radiol (NY), 2021, 46(4): 1726-1736.
[13]	Ayyagari R, Powell T, Staib L, et al. Prostatic artery embolization using 100-300-μm trisacryl gelatin microspheres to treat lower urinary tract symptoms attributable to benign prostatic hyperplasia: a single-center outcomes analysis with medium-term follow-up[J]. J Vasc Interv Radiol, 2020, 31(1): 99-107.
[14]	de Assis AM, Maciel MS, Moreira AM, et al. Prostate zonal volumetry as a predictor of clinical outcomes for prostate artery embolization[J]. Cardiovasc Intervent Radiol, 2017, 40(2):245-251.
[15]	吴少杰, 蔡森林, 唐仪, 等. 介入栓塞与经尿道电切术治疗高龄良性前列腺增生症临床对比[J]. 介入放射学杂志, 2019, (2): 179-183.
[16]	Lin YT, Pereira H, Pellerin O, et al. Four-year impact of voiding and storage symptoms in patients with benign prostatic hyperplasia treated with prostatic artery embolization[J]. J Vasc Interv Radiol, 2020, 31(9): 1460-1466.
[17]	Sun F, Lucas-Cava V, Sánchez-Margallo FM. Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review[J]. Transl Androl Urol, 2020, 9(4): 1754-1768.
[18]	Kozlowski R, Kershen RT, Siroky MB, et al. Chronic ischemia alters prostate structure and reactivity in rabbits[J]. J Urol, 2001, 165(3): 1019-1026.
[19]	Abt D, Müllhaupt G, Mordasini L, et al. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial[J]. BJU Int, 2019, 124(1):134-144.
[20]	Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolization for treatment of benign hyperplasia[J]. AJR Am J Roentgenol, 2014, 203(4): 813-821.
[21]	Shin SH, Kim JW, Kim JW, et al. Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction[J]. Korean J Urol, 2013, 54(6): 369-372.
[22]	Hirayama K, Masui K, Hamada A, et al. Evaluation of intravesical prostatic protrusion as a predictor of dutasteride-resistant lower urinary tract symptoms/benign prostatic enlargement with a high likelihood of surgical intervention[J]. Urology, 2015, 86(3):565-569.
[23]	Jeong CW, Lee S, Oh JJ, et al. Quantification of median lobe protrusion and its impact on the base surgical margin status during robot-assisted laparoscopic prostatectomy[J]. World J Urol, 2014, 32(2): 419-423.
[24]	Little MW, Boardman P, Macdonald AC, et al. Adenomatous-dominant benign prostatic hyperplasia (AdBPH) as a predictor for clinical success following prostate artery embolization: an age-matched Case-Control Study[J]. Cardiovasc Intervent Radiol, 2017, 40(5): 682-689.
[25]	Lin YT, Amouyal G, Correas JM, et al. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE[J]. Eur Radiol, 2016, 26(10): 3466-3473.

Please choose a citation manager

Content to export